Interpace Biosciences, Inc. (IDXG)
OTCMKTS
· Delayed Price · Currency is USD
0.6700
+0.0100 (5.51%)
May 2, 2025, 4:00 PM EDT
Interpace Biosciences Market Cap
Interpace Biosciences has a market cap or net worth of $3.01 million as of May 6, 2025. Its market cap has decreased by -57.49% in one year.
Market Cap
3.01M
Enterprise Value
7.40M
Revenue
46.93M
Ranking
n/a
PE Ratio
1.66
Stock Price
$0.67
Market Cap Chart
Since May 20, 1998, Interpace Biosciences's market cap has decreased from 221.97M to 3.01M, a decrease of -98.64%. That is a compound annual growth rate of -14.74%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Endo Inc. | 1.62B |
Nika Pharmaceuticals | 1.02B |
Veradigm | 746.57M |
Tian'an Technology Group | 546.22M |
Glass House Brands | 529.49M |
Elite Pharmaceuticals | 452.95M |
Northwest Biotherapeutics | 429.16M |
CytoDyn | 401.57M |